U.S., March 8 -- ClinicalTrials.gov registry received information related to the study (NCT06864351) titled 'Prospective Evaluation of OptiThyDose' on March 03.
Brief Summary: The aim of this multicentric, randomised, two-arms and single-blinded clinical trial is to prospectively evaluate OptiThyDose for Congenital hypothyroidism (CH) and Graves' disease (GD).
Study Start Date: March, 2025
Study Type: INTERVENTIONAL
Condition:
Thyroid Diseases
Congenital Hypothyroidism
Graves Disease
Intervention:
OTHER: OptiThyDose
OptiThyDose is an iterative mathematical model applied at each patient visit, consisting of three components: (i) a disease-specific pharmacometrics (PMX) model, (ii) an empirical Bayesian estimation (EBE) component, and...